Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization

Volume 23, Issue 11, November 2022, Pages 3939-3946

Nakarin Inmutto; Natthaphong Nimitrungtawee; Tanop Srisuwan; Thanate Kattipathanapong; Attaporn Jantarangkoon; Oranit Puttisri

• View Article
• PDF 1005.34 K

Efficacy of Adjuvant Transarterial Chemoembolization Combined Antiviral Therapy for HBV-Related HCC with MVI after Hepatic Resection: A Multicenter Study

Volume 23, Issue 8, August 2022, Pages 2695-2703

Yupeng Tang; Jinyu Zhang; Guixiang Chen; Jinhua Zeng; Jianxing Zeng

• View Article
• PDF 643.32 K

Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis

Volume 16, Issue 13, December 2015, Pages 5573-5578

• View Article
• PDF 926.36 K

Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies

Volume 16, Issue 17, December 2015, Pages 7871-7874

• View Article
• PDF 490.99 K

Efficacy of Transarterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma

Volume 16, Issue 14, December 2015, Pages 6159-6162

• View Article
• PDF 358.4 K

Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma

Volume 16, Issue 9, September 2015, Pages 3595-3604

• View Article
• PDF 556.17 K